297 related articles for article (PubMed ID: 33705609)
21. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.
Nakashiro K; Hara S; Shinohara Y; Oyasu M; Kawamata H; Shintani S; Hamakawa H; Oyasu R
Am J Pathol; 2004 Aug; 165(2):533-40. PubMed ID: 15277227
[TBL] [Abstract][Full Text] [Related]
22. Polyphyllin I inhibits gastric cancer cell proliferation by downregulating the expression of fibroblast activation protein alpha (FAP) and hepatocyte growth factor (HGF) in cancer-associated fibroblasts.
Dong R; Guo J; Zhang Z; Zhou Y; Hua Y
Biochem Biophys Res Commun; 2018 Mar; 497(4):1129-1134. PubMed ID: 29499193
[TBL] [Abstract][Full Text] [Related]
23. Expression array analysis of the hepatocyte growth factor invasive program.
Cecchi F; Lih CJ; Lee YH; Walsh W; Rabe DC; Williams PM; Bottaro DP
Clin Exp Metastasis; 2015 Oct; 32(7):659-76. PubMed ID: 26231668
[TBL] [Abstract][Full Text] [Related]
24. A novel rabbit anti-hepatocyte growth factor monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and mouse xenografts.
Yu Y; Chen Y; Ding G; Wang M; Wu H; Xu L; Rui X; Zhang Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):154-60. PubMed ID: 26093299
[TBL] [Abstract][Full Text] [Related]
25. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
MacDougall CA; Vargas M; Soares CR; Holzer RG; Ide AE; Jorcyk CL
Prostate; 2005 Jul; 64(2):139-48. PubMed ID: 15678502
[TBL] [Abstract][Full Text] [Related]
26. Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.
Delitto D; Zhang D; Han S; Black BS; Knowlton AE; Vlada AC; Sarosi GA; Behrns KE; Thomas RM; Lu X; Liu C; George TJ; Hughes SJ; Wallet SM; Trevino JG
Clin Cancer Res; 2016 Apr; 22(7):1787-99. PubMed ID: 26667487
[TBL] [Abstract][Full Text] [Related]
27. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
[TBL] [Abstract][Full Text] [Related]
28. TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.
Fang WB; Mafuvadze B; Yao M; Zou A; Portsche M; Cheng N
PLoS One; 2015; 10(8):e0135063. PubMed ID: 26252654
[TBL] [Abstract][Full Text] [Related]
29. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
[TBL] [Abstract][Full Text] [Related]
30. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
Zhou Z; Zhou Q; Wu X; Xu S; Hu X; Tao X; Li B; Peng J; Li D; Shen L; Cao Y; Yang L
Cancer Lett; 2020 Mar; 473():62-73. PubMed ID: 31904479
[TBL] [Abstract][Full Text] [Related]
31. RON and c-Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
Yin B; Liu Z; Wang Y; Wang X; Liu W; Yu P; Duan X; Liu C; Chen Y; Zhang Y; Pan X; Yao H; Liao Z; Tao Z
Oncol Rep; 2017 Jun; 37(6):3209-3218. PubMed ID: 28440432
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.
Tam NN; Chung SS; Lee DT; Wong YC
Carcinogenesis; 2000 Dec; 21(12):2183-91. PubMed ID: 11133807
[TBL] [Abstract][Full Text] [Related]
34. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract][Full Text] [Related]
35. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
38. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
Verras M; Lee J; Xue H; Li TH; Wang Y; Sun Z
Cancer Res; 2007 Feb; 67(3):967-75. PubMed ID: 17283128
[TBL] [Abstract][Full Text] [Related]
39. Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.
Imura Y; Nakai T; Yamada S; Outani H; Takenaka S; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
Cancer Sci; 2016 Dec; 107(12):1867-1876. PubMed ID: 27779808
[TBL] [Abstract][Full Text] [Related]
40. TNF-α promotes invasive growth through the MET signaling pathway.
Bigatto V; De Bacco F; Casanova E; Reato G; Lanzetti L; Isella C; Sarotto I; Comoglio PM; Boccaccio C
Mol Oncol; 2015 Feb; 9(2):377-88. PubMed ID: 25306394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
